Global Liquid Tumor Biopsy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 125571
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Liquid Tumor Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Liquid Tumor Biopsy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinical Laboratories accounting for % of the Liquid Tumor Biopsy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ctDNA segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Liquid Tumor Biopsy include Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, and QIAGEN N.V., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Liquid Tumor Biopsy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

ctDNA

CTC

Market segment by Application, can be divided into

Clinical Laboratories

Hospital

Market segment by players, this report covers

Abbott Laboratories

Bio-Rad Laboratories

F. Hoffmann-La Roche

Illumina

QIAGEN N.V.

Thermo Fisher Scientific

Amoy Diagnostics

HaploX

Whole Genome Sequencing

Burning Rock Biotech

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Liquid Tumor Biopsy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Liquid Tumor Biopsy, with revenue, gross margin and global market share of Liquid Tumor Biopsy from 2019 to 2022.

Chapter 3, the Liquid Tumor Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Liquid Tumor Biopsy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Liquid Tumor Biopsy research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Liquid Tumor Biopsy

1.2 Classification of Liquid Tumor Biopsy by Type

1.2.1 Overview: Global Liquid Tumor Biopsy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Liquid Tumor Biopsy Revenue Market Share by Type in 2021

1.2.3 ctDNA

1.2.4 CTC

1.3 Global Liquid Tumor Biopsy Market by Application

1.3.1 Overview: Global Liquid Tumor Biopsy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinical Laboratories

1.3.3 Hospital

1.4 Global Liquid Tumor Biopsy Market Size & Forecast

1.5 Global Liquid Tumor Biopsy Market Size and Forecast by Region

1.5.1 Global Liquid Tumor Biopsy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Liquid Tumor Biopsy Market Size by Region, (2017-2022)

1.5.3 North America Liquid Tumor Biopsy Market Size and Prospect (2017-2028)

1.5.4 Europe Liquid Tumor Biopsy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Liquid Tumor Biopsy Market Size and Prospect (2017-2028)

1.5.6 South America Liquid Tumor Biopsy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Liquid Tumor Biopsy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Liquid Tumor Biopsy Market Drivers

1.6.2 Liquid Tumor Biopsy Market Restraints

1.6.3 Liquid Tumor Biopsy Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Liquid Tumor Biopsy Product and Solutions

2.1.4 Abbott Laboratories Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Bio-Rad Laboratories

2.2.1 Bio-Rad Laboratories Details

2.2.2 Bio-Rad Laboratories Major Business

2.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Product and Solutions

2.2.4 Bio-Rad Laboratories Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.3 F. Hoffmann-La Roche

2.3.1 F. Hoffmann-La Roche Details

2.3.2 F. Hoffmann-La Roche Major Business

2.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Product and Solutions

2.3.4 F. Hoffmann-La Roche Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.4 Illumina

2.4.1 Illumina Details

2.4.2 Illumina Major Business

2.4.3 Illumina Liquid Tumor Biopsy Product and Solutions

2.4.4 Illumina Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Illumina Recent Developments and Future Plans

2.5 QIAGEN N.V.

2.5.1 QIAGEN N.V. Details

2.5.2 QIAGEN N.V. Major Business

2.5.3 QIAGEN N.V. Liquid Tumor Biopsy Product and Solutions

2.5.4 QIAGEN N.V. Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 QIAGEN N.V. Recent Developments and Future Plans

2.6 Thermo Fisher Scientific

2.6.1 Thermo Fisher Scientific Details

2.6.2 Thermo Fisher Scientific Major Business

2.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Product and Solutions

2.6.4 Thermo Fisher Scientific Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.7 Amoy Diagnostics

2.7.1 Amoy Diagnostics Details

2.7.2 Amoy Diagnostics Major Business

2.7.3 Amoy Diagnostics Liquid Tumor Biopsy Product and Solutions

2.7.4 Amoy Diagnostics Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Amoy Diagnostics Recent Developments and Future Plans

2.8 HaploX

2.8.1 HaploX Details

2.8.2 HaploX Major Business

2.8.3 HaploX Liquid Tumor Biopsy Product and Solutions

2.8.4 HaploX Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 HaploX Recent Developments and Future Plans

2.9 Whole Genome Sequencing

2.9.1 Whole Genome Sequencing Details

2.9.2 Whole Genome Sequencing Major Business

2.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Product and Solutions

2.9.4 Whole Genome Sequencing Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Whole Genome Sequencing Recent Developments and Future Plans

2.10 Burning Rock Biotech

2.10.1 Burning Rock Biotech Details

2.10.2 Burning Rock Biotech Major Business

2.10.3 Burning Rock Biotech Liquid Tumor Biopsy Product and Solutions

2.10.4 Burning Rock Biotech Liquid Tumor Biopsy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Burning Rock Biotech Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Liquid Tumor Biopsy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Liquid Tumor Biopsy Players Market Share in 2021

3.2.2 Top 10 Liquid Tumor Biopsy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Liquid Tumor Biopsy Players Head Office, Products and Services Provided

3.4 Liquid Tumor Biopsy Mergers & Acquisitions

3.5 Liquid Tumor Biopsy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Liquid Tumor Biopsy Revenue and Market Share by Type (2017-2022)

4.2 Global Liquid Tumor Biopsy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Liquid Tumor Biopsy Revenue Market Share by Application (2017-2022)

5.2 Global Liquid Tumor Biopsy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Liquid Tumor Biopsy Revenue by Type (2017-2028)

6.2 North America Liquid Tumor Biopsy Revenue by Application (2017-2028)

6.3 North America Liquid Tumor Biopsy Market Size by Country

6.3.1 North America Liquid Tumor Biopsy Revenue by Country (2017-2028)

6.3.2 United States Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

6.3.3 Canada Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

6.3.4 Mexico Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Liquid Tumor Biopsy Revenue by Type (2017-2028)

7.2 Europe Liquid Tumor Biopsy Revenue by Application (2017-2028)

7.3 Europe Liquid Tumor Biopsy Market Size by Country

7.3.1 Europe Liquid Tumor Biopsy Revenue by Country (2017-2028)

7.3.2 Germany Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

7.3.3 France Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

7.3.5 Russia Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

7.3.6 Italy Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2017-2028)

8.2 Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2017-2028)

8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Region

8.3.1 Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2017-2028)

8.3.2 China Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8.3.3 Japan Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8.3.4 South Korea Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8.3.5 India Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

8.3.7 Australia Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Liquid Tumor Biopsy Revenue by Type (2017-2028)

9.2 South America Liquid Tumor Biopsy Revenue by Application (2017-2028)

9.3 South America Liquid Tumor Biopsy Market Size by Country

9.3.1 South America Liquid Tumor Biopsy Revenue by Country (2017-2028)

9.3.2 Brazil Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

9.3.3 Argentina Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2017-2028)

10.2 Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2017-2028)

10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Country

10.3.1 Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2017-2028)

10.3.2 Turkey Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

10.3.4 UAE Liquid Tumor Biopsy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Liquid Tumor Biopsy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Liquid Tumor Biopsy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Liquid Tumor Biopsy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Liquid Tumor Biopsy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Liquid Tumor Biopsy Revenue Market Share by Region (2023-2028)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Liquid Tumor Biopsy Product and Solutions

Table 9. Abbott Laboratories Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 11. Bio-Rad Laboratories Major Business

Table 12. Bio-Rad Laboratories Liquid Tumor Biopsy Product and Solutions

Table 13. Bio-Rad Laboratories Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 15. F. Hoffmann-La Roche Major Business

Table 16. F. Hoffmann-La Roche Liquid Tumor Biopsy Product and Solutions

Table 17. F. Hoffmann-La Roche Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Illumina Corporate Information, Head Office, and Major Competitors

Table 19. Illumina Major Business

Table 20. Illumina Liquid Tumor Biopsy Product and Solutions

Table 21. Illumina Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. QIAGEN N.V. Corporate Information, Head Office, and Major Competitors

Table 23. QIAGEN N.V. Major Business

Table 24. QIAGEN N.V. Liquid Tumor Biopsy Product and Solutions

Table 25. QIAGEN N.V. Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 27. Thermo Fisher Scientific Major Business

Table 28. Thermo Fisher Scientific Liquid Tumor Biopsy Product and Solutions

Table 29. Thermo Fisher Scientific Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Amoy Diagnostics Corporate Information, Head Office, and Major Competitors

Table 31. Amoy Diagnostics Major Business

Table 32. Amoy Diagnostics Liquid Tumor Biopsy Product and Solutions

Table 33. Amoy Diagnostics Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. HaploX Corporate Information, Head Office, and Major Competitors

Table 35. HaploX Major Business

Table 36. HaploX Liquid Tumor Biopsy Product and Solutions

Table 37. HaploX Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Whole Genome Sequencing Corporate Information, Head Office, and Major Competitors

Table 39. Whole Genome Sequencing Major Business

Table 40. Whole Genome Sequencing Liquid Tumor Biopsy Product and Solutions

Table 41. Whole Genome Sequencing Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Burning Rock Biotech Corporate Information, Head Office, and Major Competitors

Table 43. Burning Rock Biotech Major Business

Table 44. Burning Rock Biotech Liquid Tumor Biopsy Product and Solutions

Table 45. Burning Rock Biotech Liquid Tumor Biopsy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Liquid Tumor Biopsy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Liquid Tumor Biopsy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Liquid Tumor Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Liquid Tumor Biopsy Players Head Office, Products and Services Provided

Table 50. Liquid Tumor Biopsy Mergers & Acquisitions in the Past Five Years

Table 51. Liquid Tumor Biopsy New Entrants and Expansion Plans

Table 52. Global Liquid Tumor Biopsy Revenue (USD Million) by Type (2017-2022)

Table 53. Global Liquid Tumor Biopsy Revenue Share by Type (2017-2022)

Table 54. Global Liquid Tumor Biopsy Revenue Forecast by Type (2023-2028)

Table 55. Global Liquid Tumor Biopsy Revenue by Application (2017-2022)

Table 56. Global Liquid Tumor Biopsy Revenue Forecast by Application (2023-2028)

Table 57. North America Liquid Tumor Biopsy Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Liquid Tumor Biopsy Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Liquid Tumor Biopsy Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Liquid Tumor Biopsy Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Liquid Tumor Biopsy Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Liquid Tumor Biopsy Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Liquid Tumor Biopsy Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Liquid Tumor Biopsy Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Liquid Tumor Biopsy Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Liquid Tumor Biopsy Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Liquid Tumor Biopsy Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Liquid Tumor Biopsy Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Liquid Tumor Biopsy Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Liquid Tumor Biopsy Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Liquid Tumor Biopsy Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Liquid Tumor Biopsy Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Liquid Tumor Biopsy Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Liquid Tumor Biopsy Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Liquid Tumor Biopsy Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Liquid Tumor Biopsy Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Liquid Tumor Biopsy Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Liquid Tumor Biopsy Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Liquid Tumor Biopsy Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Liquid Tumor Biopsy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Liquid Tumor Biopsy Picture

Figure 2. Global Liquid Tumor Biopsy Revenue Market Share by Type in 2021

Figure 3. ctDNA

Figure 4. CTC

Figure 5. Liquid Tumor Biopsy Revenue Market Share by Application in 2021

Figure 6. Clinical Laboratories Picture

Figure 7. Hospital Picture

Figure 8. Global Liquid Tumor Biopsy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 9. Global Liquid Tumor Biopsy Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Liquid Tumor Biopsy Revenue Market Share by Region (2017-2028)

Figure 11. Global Liquid Tumor Biopsy Revenue Market Share by Region in 2021

Figure 12. North America Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 13. Europe Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Asia-Pacific Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. South America Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Middle East and Africa Liquid Tumor Biopsy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Liquid Tumor Biopsy Market Drivers

Figure 18. Liquid Tumor Biopsy Market Restraints

Figure 19. Liquid Tumor Biopsy Market Trends

Figure 20. Abbott Laboratories Recent Developments and Future Plans

Figure 21. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 22. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 23. Illumina Recent Developments and Future Plans

Figure 24. QIAGEN N.V. Recent Developments and Future Plans

Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 26. Amoy Diagnostics Recent Developments and Future Plans

Figure 27. HaploX Recent Developments and Future Plans

Figure 28. Whole Genome Sequencing Recent Developments and Future Plans

Figure 29. Burning Rock Biotech Recent Developments and Future Plans

Figure 30. Global Liquid Tumor Biopsy Revenue Share by Players in 2021

Figure 31. Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 32. Global Top 3 Players Liquid Tumor Biopsy Revenue Market Share in 2021

Figure 33. Global Top 10 Players Liquid Tumor Biopsy Revenue Market Share in 2021

Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 35. Global Liquid Tumor Biopsy Revenue Share by Type in 2021

Figure 36. Global Liquid Tumor Biopsy Market Share Forecast by Type (2023-2028)

Figure 37. Global Liquid Tumor Biopsy Revenue Share by Application in 2021

Figure 38. Global Liquid Tumor Biopsy Market Share Forecast by Application (2023-2028)

Figure 39. North America Liquid Tumor Biopsy Sales Market Share by Type (2017-2028)

Figure 40. North America Liquid Tumor Biopsy Sales Market Share by Application (2017-2028)

Figure 41. North America Liquid Tumor Biopsy Revenue Market Share by Country (2017-2028)

Figure 42. United States Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Canada Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Mexico Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Europe Liquid Tumor Biopsy Sales Market Share by Type (2017-2028)

Figure 46. Europe Liquid Tumor Biopsy Sales Market Share by Application (2017-2028)

Figure 47. Europe Liquid Tumor Biopsy Revenue Market Share by Country (2017-2028)

Figure 48. Germany Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. France Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. United Kingdom Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Russia Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Italy Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Asia-Pacific Liquid Tumor Biopsy Sales Market Share by Type (2017-2028)

Figure 54. Asia-Pacific Liquid Tumor Biopsy Sales Market Share by Application (2017-2028)

Figure 55. Asia-Pacific Liquid Tumor Biopsy Revenue Market Share by Region (2017-2028)

Figure 56. China Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Japan Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. South Korea Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. India Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Southeast Asia Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Australia Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South America Liquid Tumor Biopsy Sales Market Share by Type (2017-2028)

Figure 63. South America Liquid Tumor Biopsy Sales Market Share by Application (2017-2028)

Figure 64. South America Liquid Tumor Biopsy Revenue Market Share by Country (2017-2028)

Figure 65. Brazil Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Argentina Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Type (2017-2028)

Figure 68. Middle East and Africa Liquid Tumor Biopsy Sales Market Share by Application (2017-2028)

Figure 69. Middle East and Africa Liquid Tumor Biopsy Revenue Market Share by Country (2017-2028)

Figure 70. Turkey Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Saudi Arabia Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. UAE Liquid Tumor Biopsy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Methodology

Figure 74. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz